Navigation Links
Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research

New data on Eloxatin(R), Taxotere(R) and on three investigational agents (VEGF Trap, S-1 and TroVax(R)) will be presented at the 43rd annual ASCO meeting

BRIDGEWATER, N.J., May 29, 2007 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that a total of 375 abstracts indicative of its oncology commitment have been accepted for the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Illinois (June 1-5, 2007). The results from key studies involving the company's leading anticancer agents, Eloxatin(R) (oxaliplatin injection) and Taxotere(R) (docetaxel injection concentrate), will be presented alongside clinical trial data examining investigational agents, aflibercept (VEGF Trap), S-1 (oral fluoropyrimidine) and TroVax(R) (Therapeutic Cancer Vaccine).

Of the abstracts which have been accepted, 129 focus on Eloxatin(R), 214 on Taxotere(R), 29 on S-1, two on VEGF Trap and one on TroVax(R). One hundred and ninety three Eloxatin(R) and Taxotere(R) abstracts were also accepted for presentation at the scientific sessions, with five Eloxatin(R) and 15 Taxotere(R) abstracts to be oral communications, including one Eloxatin(R) presentation at the ASCO plenary session.

The key results presented with Eloxatin(R)-based treatment (in combination with 5FU/LV) cover clinical trials in the adjuvant (post-surgery) colon cancer (MOSAIC study) and the metastatic (advanced) colorectal cancer (NCCTG/N9741study, EORTC40983/EPOC study) settings.

Data looking at Taxotere(R)-based regimens in adjuvant and in metastatic breast cancer will be presented during the meeting.

Two phase II studies examined aflibercept (VEGF Trap) as a single agent in recurrent ovarian and lung cancers. VEGF Trap is an anti-angiogenic agent that blocks the Vascular Endothelial Growth Factor (VEGF), and is currently being investigated to assess its use in stopping tumor growth. Aflibercept is in phase
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
4. Clinical Data From Nymox BPH Drug To Be Presented at American Urological Association Meeting
5. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
6. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
7. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
8. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
9. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
10. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
11. New Data Presented on Micardis (Telmisartan) Tablets in Hypertensive Patients With Type 2 Diabetes
Post Your Comments:
(Date:9/19/2014)... Sept. 19, 2014  The board of directors of ... quarterly cash dividend of $0.42 per share.  ... to stockholders of record at the close of business ... is a global, research-based biopharmaceutical company formed in 2013 ... use its expertise, dedicated people and unique approach to ...
(Date:9/19/2014)... Sept. 19, 2014  4WEB Medical announces the formal ... and ankle osteotomy implants on the market today ... annual meeting in Chicago .  The ... a surgeon,s osteotomy needs with 74 size options included in ... offerings of only 15 to 18 implant sizes, which ...
(Date:9/19/2014)... 2014 The American Association for Homecare (AAHomecare) ... Manufacturing has joined the AAHomecare Corporate Partner Program. ... have been actively involved in AAHomecare for much ... quickly grown into a major global manufacturer of home ... AAHomecare to increase efforts on behalf of the HME ...
Breaking Medicine Technology:4WEB Medical Unveils 3D-Printed Osteotomy Truss System 2Drive Medical Design & Manufacturing Joins AAHomecare Corporate Partner Program 2
... AccessClosure, Inc., the market leader in extravascular closure devices, ... distribute the Bengal Radial Compression Band in the United ... join the Mynx™ Vascular Closure Device in AccessClosure,s portfolio ... crucial to offer a solution for our customers who ...
... Escalon Medical Corp. (Nasdaq: ESMC ) ... 30, 2010.   Consolidated product revenue from ... $30,657,000, compared with $30,600,000 in the prior fiscal year. ... Drew and Trek business units, which increased approximately 7.3% ...
Cached Medicine Technology:AccessClosure Announces Distribution Agreement for Radial Compression Band 2Escalon® Reports Fiscal 2010 Results 2Escalon® Reports Fiscal 2010 Results 3Escalon® Reports Fiscal 2010 Results 4Escalon® Reports Fiscal 2010 Results 5Escalon® Reports Fiscal 2010 Results 6Escalon® Reports Fiscal 2010 Results 7
(Date:9/20/2014)... 20, 2014 Plumbing construction services ... of 5, indicating a moderately favorable purchasing environment for ... reflects current and future pricing trends that will limit ... Other factors that negatively affect buyer power are a ... and the moderate switching costs. Buyers benefit, however, from ...
(Date:9/20/2014)... RBSEO Services, which has occupied a top ... it provides an affordable website SEO (Search Engine Optimization) ... would benefit those new and old businesses struggling to ... to pay a big amount for their website promotion. ... in top search results for their business keywords and ...
(Date:9/20/2014)... 2014 The first federal bellwether trial ... its third week in the U.S. District Court, Northern ... documents indicate that the week opened in the ... a DePuy Orthopaedics vice president, who discussed the clinical ... Pinnacle hip replacement. According to Reuters, the executive stated ...
(Date:9/20/2014)... September 20, 2014 The children of ... balanced and active play they need. An empty lot ... - Lakeview Campus was transformed into a kid-designed playspace ... 150+ volunteers from Branches (@BranchesFL), ESPN (@TeamESPN), Disney (@CitizenDisney), ... KaBOOM! believes a playground is more than a playground. ...
(Date:9/19/2014)... 2014 “Copay coupons,” a drug manufacturer ... drugs among patients with prescription drug coverage, may now ... new report from the Department of Health and ... anti-kickback laws prohibit suppliers from offering side-payments to increase ... government. , The report highlights that two recent surveys, ...
Breaking Medicine News(10 mins):Health News:Plumbing Construction Services Procurement Category Market Research Report from IBISWorld Has Been Updated 2Health News:Plumbing Construction Services Procurement Category Market Research Report from IBISWorld Has Been Updated 3Health News:Plumbing Construction Services Procurement Category Market Research Report from IBISWorld Has Been Updated 4Health News:RBSEO Services Announces Affordable Website SEO Service at Only $175 2Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 2Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 3Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 4Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 2Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 3Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 4Health News:PCMA: New OIG Report Cites Drug Manufacturer“Copay Coupon” Use in Medicare Part D 2
... , WEDNESDAY, Nov. 17 (HealthDay News) -- Resistance ... than aerobic exercise and offers other cardiovascular benefits, finds ... University in Boone, N.C., compared blood vessel (vascular) responses ... 10 repetitions of eight resistance exercises and 30 minutes ...
... News) -- The U.S. Food and Drug Administration on Wednesday ... illegal. In warning letters to the companies, the agency ... "unsafe food additive," and the companies risked further action, including ... for the claim that the addition of caffeine to these ...
... approaches to targeting diseases such as cancer has been announced ... announced the potential for more targeted treatments following their identification ... of a human cell. The research teams from Germany ... Online Publication on Nature Cell Biology ,s website. ...
... have a chance to fight health problems if they ... to medications costs thousands of lives and billions of ... to the New England Healthcare Institute. Now, researchers at ... that is three times more effective than previously studied ...
... Addiction has launched a new service for its readers: ... each monthly issue, article by article, in bite-sized chunks. To ... of the functions of a scholarly journal is to make ... and clearly as possible. We think that article titles and ...
... (HealthDay News) -- The structure of the placenta influences the ... their study, the investigators found that babies grow twice as ... and that the difference in growth rate is due to ... the mother and baby. The more intimate the connection ...
Cached Medicine News:Health News:Resistance Exercise May Offer Different Cardio Benefits 2Health News:FDA Cracks Down on Caffeinated Alcohol Drinks 2Health News:FDA Cracks Down on Caffeinated Alcohol Drinks 3Health News:Scientists announce new advance with potential for future cancer targeting 2Health News:Researchers fight America's 'other drug problem' 2Health News:Gestational Period Depends on Structure of Placenta: Research 2
Malis Curette, bayonet, titanium handle, stainless steel shaft, working distance 102 mm, length 203 mm....
Cobb Curettes, reverse angled, 11"....
Castroviejo "HM" Micro Needle Holder with Tungsten-Carbide Inserts, with catch. Serrated....
Barraquer needle holder, curved, delicate....
Medicine Products: